Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Dermatol ; 53(4): 503-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24673360

ABSTRACT

Psoriasis is a chronic inflammatory process associated with an increased risk of cardiovascular risk factors. sCD40L has been suggested to have a possible role in the pathogenesis, of psoriasis and is known to be associated with inflammation, atherogenesis and cardiovascular events. This study investigated cardiovascular risk factors (sCD40L and homocysteine) as well as subclinical atherosclerosis indicators in psoriatic patients and control subjects. The study included 56 consecutive patients with chronic plaque-type psoriasis and 53 age and gender matched healthy controls admitted to a university hospital. Serum sCD40L and homocysteine levels were measured by ELISA. Carotid artery intima-media thickness and brachial artery flow mediated dilatation (FMD) measurements were determined ultrasonographically. Subjects who had a history of cardiovascular diseases and cardiovascular risk factors and receiving any systemic treatment were excluded from the study. Plasma sCD40L levels were significantly higher in psoriasis patients compared with healthy controls (1.33±0.72 vs. 0.98±0.70 ng/ml P=0.012), whereas plasma homocysteine levels did not differ significantly between the two groups. FMD was significantly reduced in the psoriasis group compared to the controls (3.83±5.03 vs. 8.45±7.27% P=0.0001). Multiple linear regression analyses indicated a significant association between psoriasis, sCD40L, and FMD. Psoriatic patients had higher sCD40L levels than healthy controls, which may lead to an increase in cardiovascular diseases. sCD40L may be a more reliable and early predictive marker of cardiovascular events in psoriatic patients. New treatmentoptions that will be developed over sCD40L will benefit in prevention of psoriasis and its cardiovascular comorbidities.


Subject(s)
Atherosclerosis/blood , Brachial Artery/physiopathology , CD40 Ligand/blood , Carotid Intima-Media Thickness , Homocysteine/blood , Psoriasis/blood , Adult , Atherosclerosis/physiopathology , Biomarkers/blood , Brachial Artery/diagnostic imaging , Case-Control Studies , Female , Humans , Male , Middle Aged , Pilot Projects , Prospective Studies , Psoriasis/physiopathology , Regional Blood Flow , Vasodilation , Young Adult
2.
Australas J Dermatol ; 52(4): e11-3, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22070716

ABSTRACT

A considerable number of recent reports have documented mycosis fungoides resembling many other dermatoses. Due to highly variable presentations and the sometimes non-specific nature of histological findings, an accurate diagnosis of mycosis fungoides can be difficult. Erythema annulare centrifugum-like mycosis fungoides with a variety of annular, polycyclic erythematous skin lesions is a recently recognized atypical manifestation of mycosis fungoides, and only a few cases have been reported to date.


Subject(s)
Erythema/pathology , Mycosis Fungoides/pathology , Skin Neoplasms/pathology , Aged , Female , Humans , Immunohistochemistry , Mycosis Fungoides/therapy , Skin Neoplasms/therapy
4.
Am J Trop Med Hyg ; 78(3): 406-8, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18337335

ABSTRACT

Cutaneous leishmaniasis has a number of morphologic variants such as acute paronychial, chancriform, annular, palmoplantar, zosteriform, and eczematoid, which depend on the immune condition of the patients, the subspecies of the Leishmania, and the area of the localization. In recent times, the number of reports of new and rare variants of cutaneous leishmaniasis has been increasing. In this report, we describe a very rare variant of Cutaneous leishmaniasis, presented with ulceration on glabellar region and infiltrative erythematous lesions covering the center of the face, resembling erysipelas.


Subject(s)
Leishmaniasis, Cutaneous/pathology , Aged , Antiprotozoal Agents/therapeutic use , Female , Humans , Leishmaniasis, Cutaneous/drug therapy , Meglumine/therapeutic use , Meglumine Antimoniate , Organometallic Compounds/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...